---
document_datetime: 2023-09-21 21:27:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/melatonin-neurim-epar-all-authorised-presentations_en.pdf
document_name: melatonin-neurim-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8642383
conversion_datetime: 2025-12-25 09:10:44.404751
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form      | Route of Administration   | Immediate Packaging    | Pack size   |
|------------------|-------------------|------------|--------------------------|---------------------------|------------------------|-------------|
| EU/1/22/1694/001 | Melatonin Neurim  | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 7 tablets   |
| EU/1/22/1694/002 | Melatonin Neurim  | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 20 tablets  |
| EU/1/22/1694/003 | Melatonin Neurim  | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 21 tablets  |
| EU/1/22/1694/004 | Melatonin Neurim  | 2 mg       | Prolonged-release tablet | Oral use                  | blister (PVC/PVDC/alu) | 30 tablets  |